Securities adjusted its outlook on Boston Scientific (NYSE:BSX) shares, raising the price target to $130 from $110 while maintaining an Outperform rating. The revision follows a series of positive ...
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2025-02-06 05:26:02